Methenamine Hippurate

CHEMBL1201104 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

319.4 g/mol

LogP

—

Phase

4

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

Berat Molekul

319,3600 g/mol

TPSA

79,40 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1

InChI

InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2

Molecular Formula

C15H21N5O3

HBD / HBA

2 / 7

Ikatan yang Dapat Dirotasi

3

Atom Berat

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

Yes, Methenamine Hippurate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201104. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 21945. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Methenamine Hippurate di PillFYI

Struktur

Data Cepat

Rumus: C15H21N5O3
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.